Endothelial dysfunction and brachial intima-media thickness: Long term cardiovascular risk with claudication related to peripheral arterial disease: A prospective analysis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Hafner, Franz ^a   Kieninger, Andrea ^a   Meinitzer, Andreas ^a   Gary, Thomas ^a   Froehlich, Harald ^a   Haas, Elke ^a   Hackl, Gerald ^a   Eller, Philipp ^a   Brodmann, Marianne ^a   Seinost, Gerald ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

6 N,N' DIMETHYLARGININE; N(G),N(G) DIMETHYLARGININE;

ADULT; AGED; BLOOD VESSEL PARAMETERS; BRACHIAL INTIMA MEDIA THICKNESS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLAUDICATION; COHORT ANALYSIS; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW KINETICS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SEROLOGY; SURVIVOR; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; COMPLICATION; CORONARY ARTERY DISEASE; PATHOPHYSIOLOGY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 84922393174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093357     Document Type: Review

References (35)

1. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, et al. (2003) Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163: 884-892.
2. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, et al. (2009) Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 120: 2053-2061.
3. Golomb BA, Dang TT, Criqui MH (2006) Peripheral arterial disease: morbidity and mortality implications. Circulation 114: 688-699.
4. Vita JA, Keaney JF Jr (2002) Endothelial function: a barometer for cardiovascular risk? Circulation 106: 640-642.
5. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-1115.
6. Brevetti G, Silvestro A, Schiano V, Chiariello M (2003) Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108: 2093-2098.
7. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, et al. (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26: 1235-1241.
8. Stoner L, Erickson ML, Young JM, Fryer S, Sabatier MJ, et al. (2012) There's more to flow-mediated dilation than nitric oxide. J Atheroscler Thromb 19: 589-600.
9. Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, et al. (2011) Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 57: 112-121.
10. Siegerink B, Maas R, Vossen CY, Schwedhelm E, Koenig W, et al. (2013) Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study. Clin Res Cardiol 102: 193-202.
11. Schwedhelm E, Boger RH (2011) The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol 7: 275-285.
12. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, et al. (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98: 1842-1847.
13. Bauersachs J, Widder JD (2008) Endothelial dysfunction in heart failure. Pharmacol Rep 60: 119-126.
14. Marz W, Meinitzer A, Drechsler C, Pilz S, Krane V, et al. (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122: 967-975.
15. Halcox JP, Donald AE, Ellins E, Witte DR, Shipley MJ, et al. (2009) Endothelial function predicts progression of carotid intima-media thickness. Circulation 119: 1005-1012.
16. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340: 14-22.
17. Agewall S, Henareh L, Jogestrand T (2005) Intima-media complex of both the brachial artery and the common carotid artery are associated with left ventricular hypertrophy in patients with previous myocardial infarction. J Hypertens 23: 119-125.
18. Koyoshi R, Miura S, Kumagai N, Shiga Y, Mitsutake R, et al. (2012) Clinical significance of flow-mediated dilation, brachial intima-media thickness and pulse wave velocity in patients with and without coronary artery disease. Circ J 76: 1469-1475.
19. Lind L, Andersson J, Ronn M, Gustavsson T, Holdfelt P, et al. (2008) Brachial artery intima-media thickness and echogenicity in relation to lipids and markers of oxidative stress in elderly subjects:-the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) Study. Lipids 43: 133-141.
20. Hafner F, Seinost G, Gary T, Froehlich H, Pilger E, et al. (2010) Are flowmediated vasodilatation and intima-media thickness of the brachial artery associated with restenosis after endovascular treatment of peripheral arterial occlusive disease? Eur Radiol 20: 2533-2540.
21. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, et al. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flowmediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265.
22. Ducharme A, Dupuis J, McNicoll S, Harel F, Tardif JC (1999) Comparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects. Am J Cardiol 84: 952-954, A958.
23. Kervancioglu S, Davutoglu V, Ozkur A, Sezen Y, Kervancioglu R, et al. (2004) Carotid and brachial intima-media thickness, arterial diameter and resistivity indices in aortic regurgitation. Acta Radiol 45: 815-818.
24. Hustad S, Eussen S, Midttun O, Ulvik A, van de Kant PM, et al. (2012) Kinetic modeling of storage effects on biomarkers related to B vitamin status and onecarbon metabolism. Clin Chem 58: 402-410.
25. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA (2002) Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303: 131-137.
26. Meinitzer A, Puchinger M, Winklhofer-Roob BM, Rock E, Ribalta J, et al. (2007) Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method. Clin Chim Acta 384: 141-148.
27. White CJ, Gray WA (2007) Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation 116: 2203-2215.
28. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, et al. (2008) Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300: 197-208.
29. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, et al. (2004) Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109: 733-739.
30. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, et al. (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326: 381-386.
31. Allan RB, Delaney CL, Miller MD, Spark JI (2013) A Comparison of Flowmediated Dilatation and Peripheral Artery Tonometry for Measurement of Endothelial Function in Healthy Individuals and Patients with Peripheral Arterial Disease. Eur J Vasc Endovasc Surg 45: 263-269.
32. Black MA, Cable NT, Thijssen DH, Green DJ (2008) Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension 51: 203-210.
33. Canga A, Kocaman SA, Durakoglugil ME, Cetin M, Erdogan T, et al. (2013) Increased carotid and brachial intima-media thickness is related to diffuse coronary involvement rather than focal lesions. Angiology 64: 356-363.
34. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, et al. (2008) Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 72: 1879-1884.
35. Boger RH, Endres HG, Schwedhelm E, Darius H, Atzler D, et al. (2011) Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. J Intern Med 269: 349-361.